M&T Bank Corp Alnylam Pharmaceuticals, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 8,645 shares of ALNY stock, worth $2.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,645

Holding current value

$2.1 Million

% of portfolio

0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 19, 2024	BUY	$233.81 - $287.01 $2.02 Million - $2.48 Million	8,645 New	8,645 $2.38 Million
Q2 2024 Jul 31, 2024	BUY	$143.31 - $247.0 $288,483 - $497,211	2,013 Added 31.33%	8,439 $2.05 Million
Q1 2024 May 07, 2024	SELL	$146.51 - $198.2 $54,062 - $73,135	-369 Reduced 5.43%	6,426 $960,000
Q4 2023 Feb 06, 2024	SELL	$151.41 - $196.57 $27,102 - $35,186	-179 Reduced 2.57%	6,795 $1.3 Million
Q3 2023 Nov 02, 2023	BUY	$170.77 - $211.65 $21,175 - $26,244	124 Added 1.81%	6,974 $1.24 Million
Q2 2023 Aug 09, 2023	SELL	$185.01 - $212.05 $3,700 - $4,241	-20 Reduced 0.29%	6,850 $1.3 Million
Q1 2023 May 11, 2023	BUY	$182.66 - $235.53 $120,738 - $155,685	661 Added 10.65%	6,870 $1.38 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $7,792 - $10,135	-42 Reduced 0.63%	6,590 $1.57 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $70,686 - $91,939	-381 Reduced 5.78%	6,209 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $289,410 - $484,648	2,089 Added 45.98%	6,632 $1.32 Million
Q2 2022 Aug 05, 2022	SELL	$120.42 - $169.29 $14,329 - $20,145	-119 Reduced 2.55%	4,543 $662,000
Q1 2022 May 09, 2022	BUY	$127.18 - $173.91 $136,718 - $186,953	1,075 Added 29.97%	4,662 $763,000
Q4 2021 Feb 07, 2022	BUY	$159.56 - $209.29 $2,393 - $3,139	15 Added 0.42%	3,587 $608,000
Q3 2021 Oct 28, 2021	BUY	$169.75 - $207.73 $2,546 - $3,115	15 Added 0.42%	3,572 $674,000
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $15,435 - $21,226	-120 Reduced 3.26%	3,557 $604,000
Q1 2021 May 06, 2021	SELL	$126.83 - $175.69 $16,487 - $22,839	-130 Reduced 3.41%	3,677 $519,000
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $12,174 - $14,553	-99 Reduced 2.53%	3,807 $495,000
Q3 2020 Nov 06, 2020	SELL	$121.19 - $165.49 $37,932 - $51,798	-313 Reduced 7.42%	3,906 $569,000
Q2 2020 Jul 29, 2020	BUY	$104.21 - $156.44 $55,856 - $83,851	536 Added 14.55%	4,219 $626,000
Q1 2020 May 14, 2020	SELL	$93.12 - $133.99 $40,786 - $58,687	-438 Reduced 10.63%	3,683 $402,000
Q4 2019 Feb 07, 2020	SELL	$74.51 - $124.23 $53,051 - $88,451	-712 Reduced 14.73%	4,121 $475,000
Q3 2019 Nov 12, 2019	BUY	$70.9 - $87.82 $11,131 - $13,787	157 Added 3.36%	4,833 $388,000
Q2 2019 Aug 12, 2019	SELL	$65.86 - $92.79 $41,162 - $57,993	-625 Reduced 11.79%	4,676 $339,000
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $291 - $373	-4 Reduced 0.08%	5,301 $495,000
Q4 2018 Feb 01, 2019	BUY	$62.67 - $88.33 $11,781 - $16,606	188 Added 3.67%	5,305 $387,000
Q3 2018 Nov 09, 2018	BUY	$87.52 - $122.67 $33,345 - $46,737	381 Added 8.04%	5,117 $448,000
Q2 2018 Aug 10, 2018	BUY	$88.31 - $107.8 $46,186 - $56,379	523 Added 12.41%	4,736 $466,000
Q1 2018 May 04, 2018	BUY	$115.92 - $148.54 $11,939 - $15,299	103 Added 2.51%	4,213 $502,000
Q4 2017 Feb 06, 2018	BUY	$114.49 - $139.98 $5,724 - $6,998	50 Added 1.23%	4,110 $522,000
Q3 2017 Nov 13, 2017	SELL	$72.53 - $118.27 $5,077 - $8,278	-70 Reduced 1.69%	4,060 $477,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,130	4,130 $331,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.02 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.07 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.32 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.28 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.2 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account